News | June 24, 2024
AstraZeneca Pharma India updates on exploring contract manufacturer
The company will now explore a buyer for its manufacturing site and exit in due course
The company will now explore a buyer for its manufacturing site and exit in due course
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
Subscribe To Our Newsletter & Stay Updated
